Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Research domains include obesity, metabolic regulation, and combination incretin-based therapies
The TRIUMPH-4 trial (December 2025) achieved 28.7% average weight loss (71.2 lbs from a 248.5 lb baseline) at 68 weeks with 12mg the highest weight loss efficacy recorded for any obesity medication to date
The timing of onset can varysome patients develop rashes shortly after starting treatment, whilst others may experience delayed reactions after weeks or months of use
The New York Times analysis suggests that increased competition could drive generic prices down to approximately $15 monthly, representing a 96% reduction from current brand-name costs
US$ 24.21
US$ 24.44
US$ 27.46
US$ 25.88
US$ 22.50
US$ 23.73
US$ 23.31
